Regeneron’s new antibody cocktail therapy for high risk category patients proves effective

Regeneron has released their antibody cocktail for treating mild to severe cases of COVID-19. Their antibody cocktail consists of casirivimab and imdevimab both of which are monoclonal antibodies which when given together have been shown to have significant anti-viral activity against COVID-19 for patients who are in the high risk category (defined extensively here) forContinue reading “Regeneron’s new antibody cocktail therapy for high risk category patients proves effective”